Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214161 · ClinicalTrials.gov registry record · NA
Intracervical Lidocaine Gel for IUD Insertional Pain
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01214161 is a NA study that has completed, run by Columbia University. The registered enrollment target is 200 participants.
The verdict
NCT01214161, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The intrauterine device (IUD) is a form of birth control that is extremely effective and safe, even in women who have not yet had children. Women can experience high levels of pain when the IUD is placed inside the uterus, and fear of this pain could be a reason that women decide not to use this method. This study will randomly (like flipping a coin) assign women who have chosen the IUD as their contraceptive into two groups. One group will have lidocaine anesthetic gel placed into their cervix prior to having the IUD inserted; the other will have an inert gel placed into their cervix instead. The level of pain at three different time points on a 10cm scale and the patient's satisfaction with the procedure will be compared between the two groups to see if using lidocaine gel helps decrease IUD insertional pain
Interventions
- OTHER placebo
- DRUG 2% lidocaine gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01214161
The ClinicalTrials.gov registry entry for NCT01214161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01214161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01214161 about?
NCT01214161 is a clinical study titled "Intracervical Lidocaine Gel for IUD Insertional Pain". The intrauterine device (IUD) is a form of birth control that is extremely effective and safe, even in women who have not yet had children. Women can experience high levels of pain when the IUD is placed inside the uterus, and fear of this pain could be a reason that women decide not to use this met...
What is the current status of trial NCT01214161?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2010-10. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01214161?
The interventions under investigation include: placebo (OTHER), 2% lidocaine gel (DRUG).
Who is sponsoring clinical trial NCT01214161?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.